Febuxostat

Welcome to Dwaey, specifically on Febuxostat page.
This medicine contains important and useful components, as it consists of
Febuxostat is available in the market in concentration.

Generic Name of Febuxostat - Learn More

Febuxostat

Febuxostat Precaution - What You Need to Know

Febuxostat should be used with caution in special populations, particularly in pregnant or breastfeeding women, as its safety profile in these groups has not been well established. It is classified under FDA pregnancy category C, meaning animal studies have shown some risks, but no well-controlled studies have been conducted in humans. It is generally recommended that febuxostat be avoided during pregnancy unless clearly needed. The drug is excreted in breast milk, so breastfeeding is not recommended during febuxostat therapy. Patients with severe hepatic impairment should also avoid this drug due to the potential for increased drug levels. Additionally, febuxostat should be used with caution in patients with a history of cardiovascular disease, especially those who have recently experienced a heart attack or stroke, due to concerns regarding the potential for increased cardiovascular risks. Monitoring parameters include liver function tests, renal function tests, and uric acid levels to assess efficacy. Regular blood pressure checks are advised, as febuxostat can potentially increase the risk of cardiovascular events in certain populations. This medication is not considered to have significant misuse or dependency potential, as it does not produce effects associated with addiction or substance abuse.

Febuxostat Indication - Uses and Benefits

Febuxostat is primarily indicated for the chronic management of hyperuricemia associated with gout. It is used to reduce serum uric acid levels, thereby helping to prevent gout attacks and related complications such as tophi formation and joint damage. It is particularly indicated for patients who are unable to tolerate allopurinol or for those with contraindications to this older medication. Febuxostat may be used as part of a long-term management strategy in adults with gout, helping to reduce the frequency and severity of flare-ups. Its mechanism involves inhibiting xanthine oxidase, an enzyme responsible for the production of uric acid. Evidence supporting its use includes clinical trials demonstrating its ability to lower uric acid levels and improve symptoms in patients with gout. Off-label uses include management of hyperuricemia in other conditions like certain types of kidney disease and cancers such as lymphoma, though these uses are less common and should be guided by clinical judgment.

Febuxostat Contraindications - Important Warnings

Febuxostat is contraindicated in patients with a known hypersensitivity to the drug or any of its components. It is also contraindicated in individuals with severe hepatic impairment, as this can lead to increased drug levels and potential toxicity. Patients with a history of cardiovascular events, such as those who have had a recent heart attack or stroke, should avoid febuxostat unless carefully monitored by a healthcare provider due to the potential for increased cardiovascular risk. It should not be used in combination with other xanthine oxidase inhibitors like allopurinol due to the risk of cumulative effects on uric acid metabolism. Additionally, febuxostat is contraindicated in pregnant and breastfeeding women unless the benefits outweigh the risks, given the limited safety data in these populations. Children under 18 years old should also generally avoid febuxostat due to the lack of established safety and efficacy data in pediatric patients.

Febuxostat Side Effects - What to Expect

Common side effects of febuxostat include gastrointestinal disturbances such as nausea, diarrhea, and abdominal pain, as well as liver function abnormalities, evidenced by elevated liver enzymes in some patients. In clinical trials, febuxostat has been associated with an increased risk of cardiovascular events, such as heart attack, stroke, and death, particularly in patients with pre-existing cardiovascular disease. Therefore, close monitoring of cardiovascular status is necessary during treatment. Less common but more serious side effects include allergic reactions, such as skin rashes or fever, and severe liver toxicity. Long-term use may lead to rare but severe side effects, such as hypersensitivity reactions, liver failure, or renal complications. To mitigate gastrointestinal side effects, febuxostat can be taken with food or antacids. Regular liver function tests are recommended to detect abnormalities early. Immediate medical attention is necessary if symptoms such as chest pain, shortness of breath, or swelling of the face or throat occur.

Febuxostat Pregnancy Category ID - Safety Information

3

Febuxostat Mode of Action - How It Works

Febuxostat works by inhibiting xanthine oxidase, an enzyme responsible for the conversion of hypoxanthine to xanthine and xanthine to uric acid. By blocking this enzyme, febuxostat reduces the production of uric acid, thereby lowering blood uric acid levels. Uric acid is a waste product of purine metabolism, and its accumulation can lead to gout and urate crystal deposits in joints and tissues. The drug's mechanism is distinct from other treatments for gout, such as allopurinol, which also inhibits xanthine oxidase but has a different chemical structure and pharmacokinetic properties. Febuxostat has a higher specificity for xanthine oxidase and may be more effective at lowering uric acid in some patients, particularly those who cannot tolerate allopurinol. This mechanism of action makes febuxostat an important option for patients who need long-term management of gout.

Febuxostat Drug Interactions - What to Avoid

Febuxostat has several significant drug-drug interactions that may alter its efficacy or increase the risk of adverse effects. It can interact with medications such as azathioprine and mercaptopurine, which are metabolized by xanthine oxidase; concomitant use can lead to dangerously elevated levels of these drugs. Febuxostat can also interact with theophylline, an asthma medication, potentially increasing its levels in the blood. Care should be taken when combining febuxostat with drugs that affect renal function or influence the metabolism of uric acid, such as diuretics, as they may alter its effectiveness. Alcohol consumption should be moderated, as excessive intake can exacerbate hyperuricemia, counteracting febuxostat’s effects. Similarly, high-purine foods may reduce the drug's effectiveness. Clinicians should monitor patients for any signs of increased uric acid levels or gout flare-ups when febuxostat is used in combination with other medications that affect uric acid metabolism. It is important to consult a healthcare provider before starting new medications while on febuxostat therapy.

Febuxostat Adult Dose - Recommended Dosage

The recommended starting dose of febuxostat for adults with gout is 40 mg once daily. If the serum uric acid level is not adequately controlled after two weeks, the dose may be increased to 80 mg once daily. The maximum allowable dose is 80 mg per day, as higher doses have not shown additional benefit and may increase the risk of adverse effects. Febuxostat should be taken orally, with or without food. It is important to monitor uric acid levels regularly during therapy to ensure the drug is effective in controlling serum uric acid. If there is no significant reduction in uric acid levels after six months, other treatment options should be considered. In patients with pre-existing kidney issues, febuxostat may require dose adjustments. Dosage titration should be done under a healthcare provider’s supervision to minimize the risk of flare-ups during initial therapy.

Febuxostat Child Dose - Dosage for Children

Febuxostat is not recommended for use in children under the age of 18 due to a lack of sufficient safety and efficacy data in pediatric populations. Its use in children with hyperuricemia or gout has not been well studied, and the potential risks in these age groups have not been clearly defined. Therefore, alternative treatments for pediatric gout or hyperuricemia should be considered. If febuxostat is used off-label for a child with a specific condition, dosing should be determined by a pediatric specialist, and close monitoring is advised.

Febuxostat Renal Dose - Dosage for Kidney Conditions

For patients with renal impairment, febuxostat should be used with caution. In individuals with mild to moderate renal impairment (creatinine clearance 30-89 mL/min), the standard dose of 40 mg once daily is typically recommended. However, if the patient’s serum uric acid level is not adequately controlled after two weeks, the dose may be increased to 80 mg per day. In patients with severe renal impairment (creatinine clearance <30 mL/min), febuxostat should be used cautiously, and dose adjustments may be necessary. It is recommended that renal function be monitored regularly during treatment. Additionally, febuxostat should be avoided in patients with end-stage renal disease on dialysis, as there is insufficient data on its safety and efficacy in this population.